Heron Therapeutics
HRTX
#7401
Rank
NZ$0.59 B
Marketcap
$3.91
Share price
-3.25%
Change (1 day)
-14.52%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.05. In 2022 the company made an earnings per share (EPS) of -$3.03 an increase over its 2021 EPS that were of -$3.93.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-35.97%
2022-$3.03-23.11%
2021-$3.93-10%
2020-$4.37-0%
2019-$4.371.21%
2018-$4.32-32.7%
2017-$6.42-19.34%
2016-$7.9654.76%
2015-$5.141.73%
2014-$5.05-16.23%
2013-$6.0391.67%
2012-$3.15-31.45%
2011-$4.59-27.06%
2010-$6.30-43.75%
2009-$11.19-57.33%
2008-$26.23-82.92%
2007-$153.5520.61%
2006-$127.31175.76%
2005-$46.17-21.43%
2004-$58.76100%
2003-$29.38-38.24%
2002-$47.57161.54%
2001-$18.19-106.46%
2000$281.372051.55%
1999$13.08839.73%
1998$1.39-105.48%
1997-$25.41-88.16%
1996-$214.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.27-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.24-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.85 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.75-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.89 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA